Search Research Articles
Browse Research Categories

CJC-1295 DAC Peptide Research

CJC-1295 with Drug Affinity Complex (DAC) is a modified GHRH analog engineered to bind albumin in the bloodstream, dramatically extending its half-life from minutes to approximately 6–8 days and enabling sustained, continuous elevation of growth hormone and IGF-1 levels. Research has explored applications in anti-aging protocols, lean muscle support, fat metabolism, and recovery optimization, with the extended half-life allowing less frequent administration than shorter-acting peptides. Studies have also examined the implications of continuous versus pulsatile GH release patterns. This section covers scientific studies on CJC-1295 DAC and its long-acting growth hormone axis research applications.

Other Popular Research Categories

Newest CJC-1295 DAC Research

CJC-1295 DAC Peptide Research – Complete Guide

CJC-1295 DAC is a synthetic growth hormone-releasing hormone analog engineered with a Drug Affinity Complex that binds covalently to serum albumin, extending its plasma half-life from approximately seven minutes to five to eight days. This CJC-1295 DAC peptide research guide covers its albumin-binding mechanism, published human clinical trial data showing sustained GH and IGF-1 elevation, pharmacokinetics, and current regulatory status....

About The Cenexa Labs Research Library

This section of the research library focuses on scientific studies involving and related research. The Cenexa Research Library compiles publicly available scientific literature and research summaries related to peptides, bioregulators, and signaling molecules. Our goal is to make complex scientific research easier to understand without requiring a technical background.
Scroll to Top
0